Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study
These findings suggest that SARS-CoV-2 infection is a risk factor for viral rebound in PLHIV on ART.
Authors
- Mu He (ORCID: https://orcid.org/0000-0002-0085-7181)
- Zhuang Cui (ORCID: https://orcid.org/0000-0001-6495-766X)
- Wangnan Cao (ORCID: https://orcid.org/0000-0002-6163-2760)
- Zihao Guo (ORCID: https://orcid.org/0000-0001-9002-0483)
- Zhen Ni (ORCID: https://orcid.org/0000-0002-3081-2830)
- Mingjian Ni (ORCID: https://orcid.org/0009-0006-0275-7914)
- Naijun Tang (ORCID: https://orcid.org/0000-0002-1177-252X)
- Kailu Wang (ORCID: https://orcid.org/0000-0002-3462-4677)
- Yongkang Ni
- Shi Zhao (ORCID: https://orcid.org/0000-0001-8722-6149)
- Kai Wang (ORCID: https://orcid.org/0000-0002-4464-4962)
- Xiaoyan He (ORCID: https://orcid.org/0000-0002-4549-3764)
- Ying Feng
- Qian He
- Ning Zhang (ORCID: https://orcid.org/0000-0002-4574-9256)
- Liang Yu (ORCID: https://orcid.org/0009-0007-3922-3454)
- Jianghong Dai (ORCID: https://orcid.org/0000-0003-1283-3969)
Institutions
- Xinjiang Medical University (CN)
- Chinese University of Hong Kong (HK)
- Peking University (CN)
- Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Region (CN)
- Taizhou Second People's Hospital (CN)
- Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (CN)
- City University of Hong Kong, Shenzhen Research Institute (CN)
- Taiwan Centers for Disease Control (TW)
- Yuxian People's Hospital (CN)
- Tianjin Medical University (CN)
- Xi’an Jiaotong-Liverpool University (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Expert Review of Anti-infective Therapy
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1080/14787210.2025.2599911
- Primary Topic
- COVID-19 epidemiological studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00